Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY:ZBH)

91.05 -1.00 (-1.09%)
Streaming Delayed Price Updated: 2:30 PM EDT, Aug 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Zimmer Biomet (ZBH) Q2 Earnings: What To Expect
Medical device company Zimmer Biomet (NYSE:ZBH) will be reporting earnings this Thursday before the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence Government World Trade
Zimmer Biomet Holdings Inc (NYSE:ZBH): A Steady Dividend Performer with Strong Profitability and Financial Stability
Zimmer Biomet (ZBH) offers steady dividends with 10+ years of payouts, strong profitability, and financial health, making it a reliable pick for long-term dividend investors. 
Via Chartmill
What Does the Market Think About Zimmer Biomet Holdings?
 
Via Benzinga
Zimmer Biomet Holdings Inc (NYSE:ZBH): A Prime Value Investing Opportunity with Strong Fundamentals and Undervalued Metrics
Zimmer Biomet (ZBH) is a top value stock with strong profitability, low P/E ratios, and solid financial health—ideal for investors seeking undervalued healthcare opportunities. 
Via Chartmill
P/E Ratio Insights for Zimmer Biomet Holdings
 
Via Benzinga
How Is The Market Feeling About Zimmer Biomet Holdings?
 
Via Benzinga
ZimVie Doubles — And Then Some — On Its Second Takeover Deal
The Zimmer Biomet spinoff is looking to head for private waters under the fund Archimed. 
Via Investor's Business Daily
Get insights into the top movers in the S&P500 index of Tuesday's pre-market session.
Discover the top S&P500 movers in Tuesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
Zimmer Biomet To Lead Orthopedic Robotics With Monogram's AI Tech
Zimmer Biomet plans to acquire Monogram and integrate its robotic knee system into its ROSA platform to support growth and product expansion through 2027. 
Via Benzinga
Topics Artificial Intelligence
Boeing, Uber, Delta Air Lines And A Health Care Stock On CNBC's 'Final Trades'
Stephanie Link, chief investment strategist and portfolio manager at Hightower, picked The Boeing Company as her final trade. 
Via Benzinga
Breaking Down Zimmer Biomet Holdings: 11 Analysts Share Their Views
 
Via Benzinga
Top S&P500 movers in Monday's pre-market session
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses. 
Via Chartmill
3 Healthcare Stocks with Questionable Fundamentals
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Artificial Intelligence Stocks
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - A Reliable Dividend Stock Worth Considering
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) offers a reliable dividend with strong profitability and reasonable valuation, making it a candidate for income investors. 
Via Chartmill
1 Profitable Stock to Target This Week and 2 to Approach with Caution
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Peering Into Zimmer Biomet Holdings's Recent Short Interest
 
Via Benzinga
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - An Undervalued Stock Worth Considering
ZIMMER BIOMET (NYSE:ZBH) is an undervalued medical device stock with strong profitability, a reasonable dividend, and improving growth prospects. A solid pick for value investors. 
Via Chartmill
3 Out-of-Favor Stocks with Questionable Fundamentals
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
2 Mid-Cap Stocks to Consider Right Now and 1 to Question
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
Via StockStory
Zimmer Biomet Holdings Inc (NYSE:ZBH) - A Reliable Dividend Stock Worth Considering
Zimmer Biomet Holdings (NYSE:ZBH) offers a reliable dividend with strong profitability and reasonable valuation, making it a solid pick for income investors. 
Via Chartmill
3 S&P 500 Stocks Facing Headwinds
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - An Undervalued Stock With Solid Fundamentals
ZIMMER BIOMET HOLDINGS (NYSE:ZBH) is an undervalued medical device stock with strong profitability, reasonable debt, and improving growth prospects, making it a candidate for value investors. 
Via Chartmill
A Look Back at Surgical Equipment & Consumables - Diversified Stocks’ Q1 Earnings: Zimmer Biomet (NYSE:ZBH) Vs The Rest Of The Pack
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared... 
Via StockStory
Topics Artificial Intelligence Economy
Zimmer Biomet Holdings Inc (NYSE:ZBH) - A Reliable Dividend Stock Worth Considering
Zimmer Biomet Holdings (NYSE:ZBH) offers a reliable dividend with strong profitability and decent financial health, making it a candidate for income investors. 
Via Chartmill
Gapping S&P500 stocks in Monday's session
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
ZBH Q1 Earnings Call: Revenue Tops Expectations, Guidance Lowered Amid Tariff and Integration Headwinds
Medical device company Zimmer Biomet (NYSE:ZBH) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 1.1% year on year to $1.91 billion. Its non-GAAP profit of $1.81 per... 
Via StockStory
Topics Economy World Trade
Assessing Zimmer Biomet Holdings: Insights From 10 Financial Analysts
 
Via Benzinga
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
ZIMMER BIOMET HOLDINGS INC has a stellar value proposition. NYSE:ZBH not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point. 
Via Chartmill
These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results
 
Via Benzinga
Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal
Zimmer Biomet Q1 sales rose 1.1% to $1.91 billion; FY25 EPS outlook trimmed but revenue growth forecast lifted following Paragon 28 acquisition. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.